Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» FDA Decision On MAP's Levadex Approaching, Stock Starting To Reflect Optimism
FDA Decision On MAP's Levadex Approaching, Stock Starting To Reflect Optimism
FDA Decision On MAP's Levadex Approaching, Stock Starting To Reflect Optimism
Submitted by
admin
on January 10, 2013 - 11:45am
Source:
Seeking Alpha
News Tags:
Levadex
FDA
MAP Pharmaceuticals
migraines
Headline:
FDA Decision On MAP's Levadex Approaching, Stock Starting To Reflect Optimism
Do Not Allow Advertisers to Use My Personal information
